Equity Details
Price & Market Data
Price: $7.73
Daily Change: $0.00 / 0.00%
Daily Range: $7.65 - $7.92
Market Cap: $46,247,344
Daily Volume: 24,984
Performance Metrics
1 Week: 0.26%
1 Month: -8.63%
3 Months: 1.97%
6 Months: -31.58%
1 Year: -24.47%
YTD: -13.75%
About Xilio Therapeutics, Inc. (XLO)
Data on Xilio Therapeutics, Inc. (XLO). Price: 7.73, daily change: $0.00 / 0.00%. Market cap: 46,247,344. Performance YTD and 1-year.
Company Details
Employees: 76
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.